MAK Capital Fund LP - 26 Feb 2026 SCHEDULE 13G Report for Protalix BioTherapeutics, Inc. Common Stock, $0.001 par value per share (PLX)

Filing Manager
MAK Capital Fund LP
Reporting Manager
MAK Capital Fund LP
Security
Protalix BioTherapeutics, Inc. Common Stock, $0.001 par value per share
Symbol
PLX
Shares outstanding
80,165,500 shares
Disclosed Ownership
4,649,599 shares
Ownership
5.8%
Form type
SCHEDULE 13G
Filing time
04 Mar 2026, 16:40:44 UTC
Date of event
26 Feb 2026
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
MAK Capital Fund LP 5.8% 4,649,599 0 4,649,599 /s/ Michael A. Kaufman Managing Member
MAK CAPITAL ONE LLC 5.8% 4,649,599 0 4,649,599 /s/ Michael A. Kaufman Managing Member
Kaufman Michael A 5.8% 4,649,599 0 4,649,599 /s/ Michael A. Kaufman Michael A. Kaufman